Tango Therapeutics logo

Tango Therapeutics Share Price Today

(NASDAQ: TNGX)

Tango Therapeutics share price is $2.09 & ₹181.77 as on 6 Mar 2025, 2.30 'hrs' IST

$2.09

0.25

(13.59%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Tango Therapeutics share price in Dollar and Rupees. Guide to invest in Tango Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Tango Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Tango Therapeutics share price movements

  • Today's Low: $1.81
    Today's High: $2.13

    Day's Volatility :14.82%

  • 52 Weeks Low: $1.80
    52 Weeks High: $12.02

    52 Weeks Volatility :85.02%

Tango Therapeutics (TNGX) Returns

PeriodTango Therapeutics IncIndex (Russel 2000)
3 Months
-46.97%
0.0%
6 Months
-84.25%
0.0%
1 Year
-83.72%
0.0%
3 Years
-78.02%
-11.6%

Tango Therapeutics (TNGX) Key Statistics

in dollars & INR

Previous Close
$1.84
Open
$1.84
Today's High
$2.125
Today's Low
$1.81
Market Capitalization
$205.4M
Today's Volume
$199.1K
52 Week High
$12.015
52 Week Low
$1.8
Revenue TTM
$42.1M
EBITDA
$-143.1M
Earnings Per Share (EPS)
$-1.18
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-57.58%

How to invest in Tango Therapeutics Stock (TNGX) from India?

It is very easy for Indian residents to invest directly in Tango Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Tango Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Tango Therapeutics or TNGX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Tango Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Tango Therapeutics shares which would translate to 0.416 fractional shares of Tango Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Tango Therapeutics, in just a few clicks!

Returns in Tango Therapeutics (TNGX) for Indian investors in Rupees

The Tango Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Tango Therapeutics investment value today

Current value as on today

₹23,458

Returns

₹76,542

(-76.54%)

Returns from Tango Therapeutics Stock

₹81,504 (-81.5%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Tango Therapeutics (TNGX)

-17%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Tango Therapeutics Stock from India on INDmoney has decreased by -17% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Tango Therapeutics

  • TRV GP IV, LLC

    15.59%

  • TCG Crossover Management, LLC

    9.93%

  • EcoR1 Capital, LLC

    9.83%

  • Boxer Capital Management, LLC

    9.60%

  • Boxer Capital LLC

    7.58%

  • Nextech Invest AG

    5.12%

Analyst Recommendation on Tango Therapeutics

Buy

    92%Buy

    7%Hold

    0%Sell

Based on 14 Wall street analysts offering stock ratings for Tango Therapeutics(by analysts ranked 0 to 5 stars)

Based on 14 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
13
12
11
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Tango Therapeutics Stock (TNGX)

What analysts predicted

Upside of 450.24%

Target:

$11.50

Current:

$2.09

Insights on Tango Therapeutics Stock (Ticker Symbol: TNGX)

  • Price Movement

    In the last 7 days, TNGX stock has moved down by -21.0%
  • Decreasing Revenue

    Revenue is down for the last 3 quarters, 19.87M → 4.11M (in $), with an average decrease of 53.1% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 3 quarters, -25.55M → -37.67M (in $), with an average decrease of 21.7% per quarter
  • TNGX vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.3% return, outperforming this stock by 145.8%
  • TNGX vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 47.7% return, outperforming this stock by 125.7%
  • Price to Sales

    ForTNGX every $1 of sales, investors are willing to pay $4.8, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $13.8 for every $1 of sales.

Tango Therapeutics Technicals Summary

Sell

Neutral

Buy

Tango Therapeutics is currently in a neutral trading position according to technical analysis indicators.

Tango Therapeutics (TNGX) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Tango Therapeutics Inc logo
-36.77%
-84.25%
-83.72%
-78.02%
-81.58%
Regeneron Pharmaceuticals, Inc. logo
1.3%
-41.29%
-30.51%
9.2%
42.38%
Beone Medicines Ltd logo
15.19%
34.31%
61.3%
43.16%
68.1%
Vertex Pharmaceuticals Incorporated logo
3.37%
3.77%
18.06%
106.43%
121.36%
Alnylam Pharmaceuticals, Inc. logo
-11.52%
-3.4%
62.32%
49.04%
120.93%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Tango Therapeutics Inc logo
NA
NA
NA
-1.29
-0.58
-0.25
NA
1.85
Regeneron Pharmaceuticals, Inc. logo
17.85
17.85
1.03
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.33
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Tango Therapeutics Inc logo
Buy
$205.4M
-81.58%
NA
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$74.9B
42.38%
17.85
31.07%
Beone Medicines Ltd logo
NA
$28.5B
68.1%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.1B
121.36%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.5B
120.93%
NA
-12.37%

About Tango Therapeutics

Tango Therapeutics, Inc., a biotechnology company, discovers and develops drugs for the treatment of cancer. Its lead program is TNG908, a synthetic lethal small molecule inhibitor of protein arginine methyltransferase 5 that is being developed as a treatment for cancers with methylthioadenosine phosphorylase deletions. The company develops TNG462, an oral small molecule methylthioadenosine-cooperative inhibitor for the treatment for cancers with methylthioadenosine phosphorylase deletions; TNG260, a co-repressor of repressor element-1 silencing transcription -selective inhibitor; TNG348, an ubiquitin-specific protease 1 inhibitor to treat patients with BRCA1 or BRCA2-mutant cancers; and Target 3 for STK11-mutant cancers. It has a strategic collaboration with Gilead Sciences, Inc. for the discovery, development, and commercialization of a pipeline of therapies for patients with cancer. Tango Therapeutics, Inc. was founded in 2017 and is headquartered in Boston, Massachusetts.
Organization
Tango Therapeutics
Employees
155
CEO
Dr. Barbara L. Weber M.D.
Industry
Miscellaneous

Management People of Tango Therapeutics

NameTitle
Dr. Barbara L. Weber M.D.
President, CEO & Director
Dr. Adam S. Crystal M.D., Ph.D.
President of Research & Development
Dr. Alan Ashworth FRS, Ph.D.
Founder & Member of Scientific Advisory Board
Dr. William G. Kaelin Jr., M.D.
Founder & Member of Scientific Advisory Board
Dr. Antoni Ribas M.D., Ph.D.
Founder & Member of Scientific Advisory Board
Mr. Timothy Redfern
Chief Financial Officer
Dr. Michael Palmieri Ph.D.
Head of Technical Operations
Mr. Jannik N. Andersen Ph.D.
Chief Scientific Officer
Mr. Douglas J. Barry Esq., J.D.
Chief Legal Officer, Chief Compliance Officer & Corporate Secretary
Ms. Julie Carretero
Chief Human Resources Officer

Important FAQs about investing in TNGX Stock from India :

What is Tango Therapeutics share price today?

Tango Therapeutics share price today stands at $2.09, Open: $1.84 ; Previous Close: $1.84 ; High: $2.13 ; Low: $1.81 ; 52 Week High: $12.02 ; 52 Week Low: $1.80.

The stock opens at $1.84, after a previous close of $1.84. The stock reached a daily high of $2.13 and a low of $1.81, with a 52-week high of $12.02 and a 52-week low of $1.80.

Can Indians buy Tango Therapeutics shares?

Yes, Indians can invest in the Tango Therapeutics (TNGX) from India.

With INDmoney, you can buy Tango Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Tango Therapeutics at zero transaction cost.

How can I buy Tango Therapeutics shares from India?

It is very easy to buy Tango Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Tango Therapeutics (TNGX) be purchased?

Yes, you can buy fractional shares of Tango Therapeutics with INDmoney app.

What are the documents required to start investing in Tango Therapeutics stocks?

To start investing in Tango Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Tango Therapeutics Stock (TNGX)?

Today’s highest price of Tango Therapeutics (TNGX) is $2.13.

Today’s lowest price of Tango Therapeutics (TNGX) is $1.81.

What is today's market capitalisation of Tango Therapeutics?

Today's market capitalisation of Tango Therapeutics TNGX is 205.4M

What is the 52 Week High and Low Range of Tango Therapeutics Stock (TNGX)?

  • 52 Week High

    $12.02

  • 52 Week Low

    $1.80

What are the historical returns of Tango Therapeutics (TNGX)?

  • 1 Month Returns

    -36.77%

  • 3 Months Returns

    -84.25%

  • 1 Year Returns

    -83.72%

  • 5 Years Returns

    -81.58%

Who is the Chief Executive Officer (CEO) of Tango Therapeutics ?

Dr. Barbara L. Weber M.D. is the current Chief Executive Officer (CEO) of Tango Therapeutics.